References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Chehadeh (2020) | Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting. | Antivir Chem Chemother | IN HIV1 group M: 7 |
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Chehadeh (2020) | Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting. | Antivir Chem Chemother | IN HIV1 group M: 7 |